PAG
MRK icon

Paladin Advisory Group’s Merck MRK Stock Holding History

Paladin Advisory Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,504
Closed -$1.28M – 412
2022
Q4 		$1.28M Sell
11,504
-123
-1% -$12.6K 1.09% 29
2022
Q3 		$1M Buy
11,627
+68
+0.6% +$6.07K 0.91% 35
2022
Q2 		$1.05M Buy
+11,559
New +$1.02M 0.91% 36
2022
Q1 		– Sell
-11,605
Closed -$889K – 426
2021
Q4 		$889K Buy
+11,605
New +$924K 0.72% 39

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Paladin Advisory Group's MRK Position: Q1 2026 in Review

Paladin Advisory Group held its Merck (MRK) position steady in Q1 2026 at 1,478 shares worth $178K. The position accounts for 0.14% of the portfolio, ranked #90.

Paladin Advisory Group first reported a position in MRK in Q1 2022 and has held it in 14 quarters since. The position peaked at $1.34M in Q2 2023. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Paladin Advisory Group held 1,478 shares of Merck worth $178K as of Q1 2026.
  • Paladin Advisory Group left its Merck share count unchanged in Q1 2026.
  • Merck made up 0.14% of Paladin Advisory Group's portfolio in Q1 2026, its #90 holding.
  • Paladin Advisory Group first reported a position in Merck in Q1 2022 and has held it in 14 quarters since.
  • Paladin Advisory Group's Merck position peaked at $1.34M in Q2 2023.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Paladin Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.